Silicon Labs (SLAB) Reports In-Line Q3 EPS, Revenues Beat; Offers 4Q Revenue Guidance Above Consensus
Get Alerts SLAB Hot Sheet
EPS Growth %: -182.1%
Financial Fact:
Interest income: 331K
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Silicon Labs (NASDAQ: SLAB) reported Q3 EPS of $0.73, in-line with the analyst estimate of $0.73. Revenue for the quarter came in at $221.35 million versus the consensus estimate of $213.04 million.
Third Quarter Financial Highlights
- IoT revenue grew to $133.2 million, up 16% sequentially and 3% year-on-year.
- Infrastructure and Automotive revenue declined to $88.2 million, down 5% sequentially and 6% year-on-year.
On a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, restructuring charges, non-cash interest expense and other costs associated with convertible notes, and certain other items as set forth in the reconciliation tables below:
- Non-GAAP gross margin was 59.5%.
- Non-GAAP R&D expenses were $56 million.
- Non-GAAP SG&A expenses were $39 million.
- Non-GAAP operating income as a percentage of revenue was 16.9%.
- Non-GAAP diluted earnings per share were $0.73.
"Third quarter revenue exceeded the high end of our guidance range at $221.3 million," said Tyson Tuttle, CEO of Silicon Labs. "Revenue was considerably stronger than expected, with our IoT products leading the way with a record quarter. We see sustained acceleration towards a more connected world, which our products are well-suited to address."
GUIDANCE:
Silicon Labs sees Q4 2020 EPS of $0.68-$0.78, versus the consensus of $0.73. Silicon Labs sees Q4 2020 revenue of $221-231 million, versus the consensus of $214.37 million.
- Non-GAAP gross margin at approximately 59%.
- Non-GAAP operating expenses at approximately $95 million.
- Non-GAAP effective tax rate at 13.0%.
- Non-GAAP diluted earnings per share between $0.68 and $0.78.
For earnings history and earnings-related data on Silicon Labs (SLAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) stock slips despite earnings beat
- Merck (MRK) hikes outlook for 2024 as Q1 print beats analyst estimates
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
Create E-mail Alert Related Categories
Corporate News, Earnings, Guidance, Hot Guidance, Management CommentsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!